Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Applications
ELISA
Western Blot
3D Cell Culture
Spatial Biology
PCR
Quantitative PCR
Digital PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Application Notes
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Antibodies
Antibodies
Iscalimab
Iscalimab from MedChemExpress
Be the first to write a review!
Citations:
(4)
Supplier Page
Supplier Page from
MedChemExpress for
Iscalimab
Bulk Request
Description
Iscalimab (CFZ-533) is a non-depleting IGg1 monoclonal antibody targeting
CD40
(
K
D
: 0.3 nM). Iscalimab can be used for research of Graves' hyperthyroidism and autoimmune diseases
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
Iscalimab
Company
MedChemExpress
Price
$450.00
Supplier Page
View Company Product Page
Catalog Number
HY-P99670
Type
Chemical
Applications
Bioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Quantity
1 mg
Purity
99.64%
Research Area
Metabolic Disease; Inflammation/Immunology
Add to Compare List
MedChemExpress
1 Deer Park Drive, Suite F
MONMOUTH JUNCTION
,
NJ
08852
United States
Phone
: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910
Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com
Company Profile
Website:
medchemexpress.com
Citations (4)
(1)
Immunosuppression Profile of CFZ533 (Iscalimab), a Non-Depleting Anti-CD40 Antibody, and the Presence of Opportunistic Infections in a Rhesus Monkey Toxicology Study
Toxicologic pathology
July 1, 2022
Flandre TD, Mansfield KG, Espié PJ, Rubic-Schneider T, Ulrich P.
(2)
A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism-A Proof-of-Concept Trial
The Journal of clinical endocrinology and metabolism
March 1, 2020
Kahaly GJ, Stan MN, Frommer L, Gergely P, Colin L, Amer A, Schuhmann I, Espie P, Rush JS, Basson C,
et al
.
(3)
Characterization of the in vitro and in vivo properties of CFZ533, a blocking and non-depleting anti-CD40 monoclonal antibody
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
December 1, 2018
Ristov J, Espie P, Ulrich P, Sickert D, Flandre T, Dimitrova M, Müller-Ristig D, Weider D, Robert G, Schmutz P,
et al
.
(4)
A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
November 1, 2015
Cordoba F, Wieczorek G, Audet M, Roth L, Schneider MA, Kunkler A, Stuber N, Erard M, Ceci M, Baumgartner R,
et al
.
<<
<
>
>>
Reviews
Be the First to Write a Review!
Iscalimab from MedChemExpress
Supplier Page
View Company Product Page
$450.00
Product Specs
Company Info
Citations
Reviews
Back To Top